REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dinafarma S.A. DE C.V. (Mexico)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Dinafarma S.A. DE C.V. Profile Updated: December 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Dinafarma S.A. DE C.V. is an enterprise in Mexico, with the main office in Alvaro Obregon. It operates in the Pharmaceutical and Medicine Manufacturing sector. It was incorporated on July 01, 2004. The total number of employees is currently 15 (2024). The company’s latest financial report indicates a net sales revenue drop of 15.76% in 2023. There was a total negative growth of 3.92% in Dinafarma S.A. DE C.V.’s total assets over the same period.

Headquarters
Blvd. Adolfo Lopez Mateos 314, Col. Tlacopac
Alvaro Obregon; Postal Code: 01049

Contact Details: Purchase the Dinafarma S.A. DE C.V. report to view the information.

Basic Information
Total Employees:
Purchase the Dinafarma S.A. DE C.V. report to view the information.
Financial Auditors:
Purchase the Dinafarma S.A. DE C.V. report to view the information.
Incorporation Date:
July 01, 2004
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Dinafarma S.A. DE C.V. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MXN. Absolute financial data is included in the purchased report.
Net sales revenue
-15.76%▼
Total operating revenue
-15.76%▼
Operating profit (EBIT)
372.66%▲
Net Profit (Loss) for the Period
N/A
Total assets
-3.92%▼
Total equity
7.77%▲
Operating Profit Margin (ROS)
6.69%▲
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
0.75%▲
Quick Ratio
-0.18%▼
Cash Ratio
-0.04%▼

Similar companies

Johnson & Johnson De Mexico S.A. De C.V.
 
Genomma Lab Internacional, S.A.B. DE C.V.
Productos Maver S.A. DE C.V.
 
Laboratorios Grossman S.A.
Aspen Labs S.A. de C.V.
 
Productos Farmaceuticos S.A. De C.V.
Comercializadora Veterinaria Guayangareo S.A. DE C.V.
 
Aaatec S.A. DE C.V.
Cohmedic S.A. DE C.V.
 
Farmabiot S.A. DE C.V.
Pvh Distribucion S.A. DE C.V.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo